Major Growth Driver Identified in 2025 Canine Arthritis Treatment Market: Rising Pet Ownership Rates Drive Growth In Canine Arthritis Treatment Market

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Canine Arthritis Treatment Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In the past few years, the market size of canine arthritis treatment has significantly expanded. The projections show it will increase from $2.35 billion in 2024 to $2.48 billion in 2025, with a compound annual growth rate (CAGR) of 5.6%. The remarkable growth within the historical period is due to factors such as an increasing number of aging pets, heightened awareness among pet owners about pet health, an emphasis on preventive care, growth in disposable income, and increased spending on veterinary care.

Canine Arthritis Treatment Market Size Forecast: What's the Projected Valuation by 2029?
The market for treatments of canine arthritis is anticipated to witness considerable expansion in the near future. The market value is projected to reach $3.06 billion by 2029 with a 5.4% compound annual growth rate (CAGR). The surge anticipated within the forecast period is mainly due to the increase in pet insurance policies, the prevalence of arthritis cases, growing numbers of pet owners, the demand for treatments involving less invasive surgeries and the escalating instances of arthritis in dogs. Key trends for the forecast period encompass breakthrough treatments, veterinary medicine advancements, the need for advanced treatment methods, technological integration and innovation.

View the full report here:
https://www.thebusinessresearchcompany.com/report/canine-arthritis-treatment-global-market-report

What Are the Drivers Transforming the Canine Arthritis Treatment Market?
The increased rate of pet adoption is anticipated to spur the expansion of the canine arthritis treatment market. The term 'pet ownership' encompasses the duties and care given by persons or families to ensure the needs, welfare, and companionship of pets kept mainly for enjoyment rather than for practical reasons. The growing pet ownership rates can be attributed to factors like alterations in lifestyle, pets being treated more humanely, and higher disposable incomes. To manage and alleviate their dogs' arthritis symptoms, pet owners resort to canine arthritis treatments, with the ultimate goal to enhance their pets' living conditions and sustain their mobility. For example, the American Pet Products Association, a US-based non-profit organization, reported in October 2023 that 86.9 million US households owned a pet. This figure represented 66% of households in 2022. Therefore, the increased pet adoption rate is propelling the canine arthritis treatment market's growth.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16007&type=smp

What Long-Term Trends Will Define the Future of the Canine Arthritis Treatment Market?
Significant businesses in the canine arthritis treatment market are pioneering novel therapies such as bedinvetmab injections, aimed at improving canine joint health and mobility. Bedinvetmab is a type of injection of monoclonal antibody that functions by identifying and neutralising nerve growth factor (NGF), a protein that plays a significant role in instigating pain and is commonly utilized in veterinary medicine. For example, Zoetis Inc., an American animal health business, gained Food and Drug Administration (FDA) approval in May 2023 for Librela, an injection of bedinvetmab. This is the first monoclonal antibody (mAb) to get FDA approval for canine use. It operates by attaching to and restricting the biological activity of canine NGF, which plays a critical role in controlling pain linked to OA. It is delivered via a subcutaneous injection once a month, presenting a practical and long-lasting solution for managing pain associated with canine OA.

Which Segments in the Canine Arthritis Treatment Market Offer the Most Profit Potential?
The canine arthritis treatment market covered in this report is segmented -

1) By Treatment Type: Drugs, Supplements, Surgical Procedures, Other Treatment Types
2) By Route Of Administration: Oral, Parenteral, Other Routes Of Administrations
3) By Arthritis Type: Osteoarthritis, Rheumatoid Arthritis, Osteochondrosis, Traumatic Arthritis
4) By Distribution Channels: Veterinary Clinics And Hospitals, Retail Pharmacies, Online Pharmacies

Subsegments:
1) By Drugs: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Disease-Modifying Osteoarthritis Drugs (DMOADs), Corticosteroids, Analgesics And Pain Relievers
2) By Supplements: Glucosamine And Chondroitin Supplements, Omega-3 Fatty Acids And Fish Oil, Hyaluronic Acid Supplements, MSM (Methylsulfonylmethane) Supplements, Collagen-Based Supplements
3) By Surgical Procedures: Joint Replacement Surgery, Arthroscopy, Osteotomy, Synovectomy
4) By Other Treatment Types: Physical Therapy, Stem Cell Therapy, Platelet-Rich Plasma (PRP) Therapy, Cold Laser Therapy (Low-Level Laser Therapy), Acupuncture

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=16007&type=smp

Which Firms Dominate the Canine Arthritis Treatment Market by Market Share and Revenue in 2025?
Major companies operating in the canine arthritis treatment market are Merck & Co. Inc., Bayer AG, Eli Lilly and Company, Zoetis Inc., Boehringer Ingelheim Animal Health, Elanco Animal Health Incorporated, Royal Canin SAS, Virbac Group, Ceva Sante Animale S.A., Hill's Pet Nutrition Inc., Vetoquinol SA, Norbrook Laboratories Limited, American Regent Inc., Thorne Healthtech Inc., VetStem Inc., Eltech K-Laser s.r.l., Liquid Health Inc, Nutri-Vet LLC, OrthoPets LLC, Rejuvenate Bio Inc.

Which Regions Offer the Highest Growth Potential in the Canine Arthritis Treatment Market?
North America was the largest region in the canine arthritis treatment market in 2024. Asia-Pacifica is expected to be the fastest-growing region in the forecast period. The regions covered in the canine arthritis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16007

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.